Ishikawa J - Search Results

1

Different Immune Reconstitution between Cord Blood and Unrelated Bone Marrow Transplantation with Relation to Chronic Graft-versus-Host Disease.

Yoshida H, Koike M, Tada Y, Nakata K, Hino A, Fuji S, Masaie H, Oka C, Higeno A, Idota A, Yamasaki T, Ishikawa J. Yoshida H, et al. Among authors: ishikawa j. Int J Hematol Oncol Stem Cell Res. 2020 Jan 1;14(1):1-10. Int J Hematol Oncol Stem Cell Res. 2020. PMID: 32337009 Free PMC article.

2

GVHD prophylaxis by tacrolimus and mini-MTX in single-unit CBT: a single institute experience.

Fuji S, Tada Y, Nakata R, Nakata K, Koike M, Kida S, Tsutsumi K, Masaie H, Yoshida H, Ishikawa J. Fuji S, et al. Among authors: ishikawa j. Int J Hematol. 2020 Feb;111(2):278-283. doi: 10.1007/s12185-019-02762-3. Epub 2019 Oct 28. Int J Hematol. 2020. PMID: 31659626

3

Expression of CD27 on peripheral CD4+ T-lymphocytes correlates with the development of severe acute graft-versus-host disease after allogeneic bone marrow transplantation.

Yoshida H, Maeda T, Ishikawa J, Inoue S, Matsunaga H, Kosugi S, Shiraga M, Oritani K, Kanakura Y, Tomiyama Y. Yoshida H, et al. Among authors: ishikawa j. Int J Hematol. 2006 Nov;84(4):367-76. doi: 10.1532/IJH97.05159. Int J Hematol. 2006. PMID: 17118766

4

Epstein-Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma.

Yagi T, Ishikawa J, Aono N, Yamashita Y, Kusakabe S, Yoshinami T, Akazawa Y, Sakai D, Yamamoto S, Hamanaka Y, Masaie H, Sugimoto N, Yoshida H, Tomita Y, Imamura F. Yagi T, et al. Among authors: ishikawa j. Int J Hematol. 2012 Feb;95(2):214-6. doi: 10.1007/s12185-011-0979-4. Epub 2011 Dec 16. Int J Hematol. 2012. PMID: 22170229

5

Significant improvement following combination treatment with mefloquine and mirtazapine in a patient with progressive multifocal leukoencephalopathy after allogeneic peripheral blood stem cell transplantation.

Yoshida H, Ohshima K, Toda J, Kusakabe S, Masaie H, Yagi T, Ishikawa J. Yoshida H, et al. Among authors: ishikawa j. Int J Hematol. 2014 Jan;99(1):95-9. doi: 10.1007/s12185-013-1471-0. Epub 2013 Nov 22. Int J Hematol. 2014. PMID: 24264833

6

Changes from imatinib mesylate to second generation tyrosine kinase inhibitors improve renal impairment with imatinib mesylate in chronic myelogenous leukemia.

Hino A, Yoshida H, Tada Y, Koike M, Minami R, Masaie H, Ishikawa J. Hino A, et al. Among authors: ishikawa j. Int J Hematol. 2016 Nov;104(5):605-611. doi: 10.1007/s12185-016-2071-6. Epub 2016 Jul 26. Int J Hematol. 2016. PMID: 27460678

7

Comparison of CHOP with THP-COP for peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective analysis using data from the population-based Osaka Cancer Registry.

Kida S, Fuji S, Morishima T, Nakata K, Miyashiro I, Ishikawa J. Kida S, et al. Among authors: ishikawa j. Int J Hematol. 2021 Aug;114(2):246-251. doi: 10.1007/s12185-021-03150-6. Epub 2021 Apr 16. Int J Hematol. 2021. PMID: 33864237

8

A multi-center retrospective analysis of patients with relapsed/refractory follicular lymphoma after third-line chemotherapy.

Fuji S, Tada Y, Nozaki K, Saito H, Ozawa T, Kida T, Kosugi S, Sugahara H, Ikeda H, Hashimoto K, Karasuno T, Ueda S, Ishikawa J, Shibayama H. Fuji S, et al. Among authors: ishikawa j. Ann Hematol. 2020 Sep;99(9):2133-2139. doi: 10.1007/s00277-020-04126-y. Epub 2020 Jun 12. Ann Hematol. 2020. PMID: 32533251

9

Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma-not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry.

Fuji S, Kida S, Nakata K, Morishima T, Miyashiro I, Ishikawa J. Fuji S, et al. Among authors: ishikawa j. Ann Hematol. 2021 Jan;100(1):157-165. doi: 10.1007/s00277-020-04308-8. Epub 2020 Oct 21. Ann Hematol. 2021. PMID: 33089366

10

Analysis of real-world data in patients with relapsed/refractory diffuse large B cell lymphoma who received salvage chemotherapy in the rituximab era.

Fuji S, Kida S, Nakata K, Morishima T, Miyashiro I, Ishikawa J. Fuji S, et al. Among authors: ishikawa j. Ann Hematol. 2021 Sep;100(9):2253-2260. doi: 10.1007/s00277-020-04342-6. Epub 2020 Nov 9. Ann Hematol. 2021. PMID: 33169198

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

746 results

Search Page

Filters